✦ LIBER ✦

Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin

✍ Scribed by Paul L. Canner; Kenneth G. Berge; Nanette K. Wenger; Jeremiah Stamler; Lawrence Friedman; Ronald J. Prineas; William Friedewald

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term mortality benefit with abcixim

✍ Keaven M Anderson; Robert M Califf; Gregg W Stone; Franz-Josef Neumann; Gilles M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 213 KB

Benefits of niacin by glycemic status in

✍ Paul L. Canner; Curt D. Furberg; Michael L. Terrin; Mark E. McGovern 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Niacin decreases myocardial infarction a

✍ Canner, Paul L.; Furberg, Curt D.; Terrin, Michael L.; McGovern, Mark E. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Benefits of Niacin in Patients With Vers

✍ Paul L. Canner; Curt D. Furberg; Mark E. McGovern 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Long term survival after coronary endart

✍ Sanjay Kumar; Sandeep Agarwala; Charlie Talbot; R Unnikrishnan Nair 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 242 KB

CULPRIT LESION REMODELING AND LONG-TERM

✍ Okura, Hiroyuki; Matsushita, Nobuya; Shimeno, Kenji; Ozaki, Takeshi; Yamagishi, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 126 KB